Our research

SC4SM provides funding to select academic groups to develop new techniques for stem cell-based safety testing. The work involves using stem cell lines that can differentiate into homogeneous populations of particular cell types. These differentiated cells have physiologically relevant characteristics, that can hopefully be used in toxicology to reliably predict the safety of new medicines.